J.P. Morgan analyst Andrea Faria Teixeira has maintained their neutral stance on CLX stock, giving a Hold rating on September 5.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Andrea Faria Teixeira’s rating is based on several factors impacting Clorox’s performance. One of the primary reasons is the company’s recent challenges with its order fulfillment process, particularly following the implementation of a new ERP system. This resulted in shipment delays and out-of-stock situations in August, which affected sales and market share. Despite these issues, Clorox has maintained its full fiscal year 2026 outlook, although the first quarter sales are expected to be at the lower end of the guidance range.
Additionally, the Hold rating reflects the current market conditions and Clorox’s competitive position. The company’s earnings volatility and lack of clear growth catalysts, combined with increased competition in key product categories, contribute to a cautious outlook. Although the price target for December 2026 has been slightly increased, it remains at a discount compared to peers, making the stock less attractive for significant investment at this time.
In another report released on September 5, TD Cowen also maintained a Hold rating on the stock with a $120.00 price target.